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The Richard Floor Biorepository supports collaborative studies of extracellular vesicles (EVs) found in
human fluids and tissue specimens. The current emphasis is on biomarkers for central nervous system
neoplasms but its structure may serve as a template for collaborative EV translational studies in other fields.
The informatic system provides specimen inventory tracking with bar codes assigned to specimens and
containers and projects, is hosted on globalized cloud computing resources, and embeds a suite of shared
documents, calendars, and video-conferencing features. Clinical data are recorded in relation to molecular EV
attributes and may be tagged with terms drawn from a network of externally maintained ontologies thus
offering expansion of the system as the field matures. We fashioned the graphical user interface (GUI) around
a web-based data visualization package. This system is now in an early stage of deployment, mainly focused
on specimen tracking and clinical, laboratory, and imaging data capture in support of studies to optimize
detection and analysis of brain tumourspecific mutations. It currently includes 4,392 specimens drawn from
611 subjects, the majority with brain tumours. As EV science evolves, we plan biorepository changes which
may reflect multi-institutional collaborations, proteomic interfaces, additional biofluids, changes in operating
procedures and kits for specimen handling, novel procedures for detection of tumour-specific EVs, and for
RNA extraction and changes in the taxonomy of EVs. We have used an ontology-driven data model and web-
based architecture with a graph theorydriven GUI to accommodate and stimulate the semantic web of EV
science.
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G
liomas are the most common type of primary
brain tumour in humans. They include 3 types
with varying levels of malignancy: astrocytoma,
oligodendroglioma, and mixed oligo-astrocytoma (1).
Glioblastoma multiforme (GBM) is the most malig-
nant and common form (WHO Grade IV) with an inci-
dence of about 3 cases/100,000 individuals per year and
a 5-year survival rate of about 3% (U.S. Central Brain
Tumor Registry; www.cbtrus.org) (2). Standard-of-care
treatment may involve surgical biopsy, partial or gross
total resection of the lesion, multiple forms of radiation,
and specific protocols for chemotherapy. These therapies
are not curative for GBM. Treatment decisions are
complicated as disease burden is monitored chiefly by
magnetic resonance imaging (MRI) and assessment of
neurologic symptoms. This presents a significant pro-
blem, as after therapy there are frequently abnormal
neuroimaging findings due to necrosis and other effects
of treatment, which may be difficult to distinguish from
tumour regrowth per se. The definitive assay remains re-
biopsy of the tumour for neuropathological analysis.
Therefore, there is a need for biomarkers to diagnose
tumours, to monitor the status of glioma recurrence
following surgery and to monitor therapeutic responses.
The identification of valid biomarkers is also important
in the management of other types of cancer, including
breast, lymphoma, melanoma, lung, pancreas, prostate,
and colon. Some biomarkers of interest include mutant/
variant mRNA of the epidermal growth factor receptor,
EGFRvIII, and isocitric dehydrogenase (IDH1/2) muta-
tions preponderantly found in gliomas for which they
correlate with survival (3,4). The scientific biomarker
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ing those of global specimen assignment and the correla-
tion of clinical, imaging, and research extracellular vesicle
(EV) data (Fig. 1).
Insofar as EVs may be regarded as fluid-borne bio-
marker vectors, a biorepository to support EV biomarker
science faces informatic challenges beyond those faced
by simple tissue biorepositories, commencing with the
need to support the benchmarking of EV biomarker
assays against solid tissue analyses (5). Moreover, since
an additional function of a biomarker is to bridge an
intrinsic biological state to a predicted clinical endpoint,
an informatic system to support EV biomarker science
likewise must record linkage between biological and
clinical states (6). The need for biospecimens throughout
cancer research has motivated the development of several
biorepositories, including offerings by federal govern-
ments, academia, and the commercial marketplace (79).
To unify some of these offerings, the United States
National Cancer Institute maintains a specimen resource
locator, which seeks in turn to aggregate catalogues from
a number of specimen banks (9). But the development
of the dual services sought of a biomarker, both to be
a bridging indicator of biological state and to provide
a surrogate measure of clinical outcome, pose informatic
and other challenges beyond the focus of the valuable
existing biorepository resources.
We report a laboratory and clinical information system
that supports this fluid-based biomarker search and
validation effort. To accommodate maturation in the
EV field, we hypothesized the need for informatics to
keep pace with scientific advances. Given hypothetical
changes in nomenclature, structural distinctions, pre-
parative techniques, proteomics, and collaborative stu-
dies, we generated narrative examples of the way in
which the system may be used and expressed these
examples as use cases. From the use cases we designed
the data model and the graphical user interface (GUI)
screens. In the future, we will compare actual usage with
projected usage, and modify the system to support EVs
science as it evolves.
The hypotheses that have driven the system design
include global collaboration, multimodal clinical data,
ontology tag, and unified data visualization.
Global collaboration hypothesis
Our major focus is the utility of EV-derived mRNAs
and non-coding RNAs as diagnostic and therapeutic
biomarkers of brain tumours. We assume that collabora-
tors with the Richard Floor Biorepository (http://www.
floorbiorepository.org/) and with the ABC2 Brain Tumor
Biomarker Consortium (http://abc2.org/) have comple-
mentary areas of interest and expertise. Global tertiary
centres with large clinical volumes may contribute human
specimens to research laboratories. When investigators
generate a new causative or correlative hypothesis, they
may seek tovalidate it by analysing specimens drawn from
archives. So to maximize efficiency, specimens may need
to be stored at and transported between many facilities
worldwide. The informatic system must offer global speci-
men inventory tracking. This is reified in this system in
the field and laboratory use cases, described further in the
Methods section.
Efficient collaboration is also advanced by the shar-
ing of documents, calendars, electronic bulletin boards,
and by live communication through video conferencing.
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these may be coupled with optional links if
they are gathered simultaneously
Fig. 1. A human subject has a disease condition affecting an internal organ that may be directly sampled at risk higher than sampling of
ﬂuids such as serum. The ﬂuids may have microvesicles whose analysis may shed light when aggregated to other clinical, laboratory and
imaging information on the status of the internal organ. The goal is to develop improved inferential models of the state of the internal
organ from ﬂuid microvesicle analysis, and use that model better to guide therapy.
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bedded this informatic system in a private Google Apps
domain (10).
Multimodal clinical data hypothesis
The detection of subtle relationships between biomarkers
or between biomarkers and clinical data may be enhanced
when information is aggregated from multiple modalities
of clinical data, such as history, comorbidities, medi-
cation, physical examination, therapeutic interventions,
laboratory results, and radiological imaging exams. For
example, the elevation of a certain EV biomarker expres-
sion when complemented by magnetic resonance perfu-
sion imaging changes might signify glioma progression
more reliably than either alone. This multimodal clinical
data hypothesis is reified in the field and clinical data use
cases described in the Use cases section.
Ontology tag hypothesis
The central nervous system (CNS) has multiple anatomic
sites for tumour development. Likewise, there are multiple
neuropathological entities and systemic entities, which
may correlate with neurologic status and EV biomarkers.
We hypothesized that there is a need to expand the scope
and flexibility of the system and thus used externally
maintained and validated ontologies to tag tissue sources,
pathological entities, and other biological events. We
anticipate the need to accommodate surprising scientific
insights which may emerge. For example, recent studies
have correlated single base pair mutations in the isocitric
dehydrogenase genes (IDH1/2) with in situ and systemic
accumulation of the substrate 2-hydroxyglutaric acid
(2HG) as well as tumour-specific promoter methyla-
tion. Each of these may correlate with predisposition to
inherited disorders, sarcoma, cholangiocarcinoma, and
acute myelogenous leukaemia (4). Moreover, a future
EV ontology, perhaps one that builds on existing work,
could be adopted (1113). The United States National
Center for Bio Medical Ontology (NCBO) maintains
a network of ontologies (14). We designed this bioreposi-
tory system to mirror those ontologies and to use their
world-recognized terms to tag data. The ontology tag
hypothesis is reified in the field, clinical data, specimen
query described above, and data archive and reporting use
cases described in the Use cases section.
Unified data visualization hypothesis
A conventional GUI typically contains a text-based menu
structure and presents tabular data as text for viewing
and editing. However, humans can grasp much greater
volumes of rich and complex datawhen presented visually
rather than textually. We hypothesized the need to accom-
modate these graphic displays when anticipating changes
in concepts of molecular gliomagenesis paths and incor-
porating recent additions to The Cancer Genome Atlas
(TCGA) related to glioma (15,16). Thus, graph methods
may prove to be convenient and clear ways to represent
networked information that consists of nodes and edges
such as complex biological data (1720). Examples of
such complex biological data include metabolic path-
way data (19,21,22), ontology networks (23), and data-
base structures that link tables with subject, diagnostic,
specimen, and outcomes data.
We anticipate the need to accommodate new directions
in the science of EVs, including speciation of those
obtained from in vitro cell lines, in situ patient specimens,
and in vivo animal models, subjected to varying forms of
centrifugation and column and filtration separation,
and then analysed by transmission electron microscopy
(TEM) imaging, immune-gold TEM, nano-particle con-
centration and size tracking, zeta potential analysis,
and lipidomics (2426). Hence, we elected to base the
GUI on a graph theory paradigm (Fig. 2). An existing
data visualization library for the display of networked
data is not sufficient for our purposes, but requires
3 additional properties. First, all elements in the GUI
must be unified into a single network graph model.
This includes programmatic functionality, data query and
editing, and meta data maintenance. Second, subject,
specimen, and ontology networks may change in re-
sponse to scientific developments. The system must
be able to introspect these data models and modify
the network graph model accordingly so that it can be
rendered on the screen by the data visualization package.
Third, the network graph GUI code must allow the user
to query, inspect, and edit data with conventional screen
forms, graphic forms, and tabular text formats in the
appropriate circumstances.
For the development of the web-based GUI, we use
an open-source space tree visualization toolkit (27). We
augmented the source code to include the additional
properties described earlier of unification, of program-
matic and data domains, data model introspection, and
interactivity. The unified data visualization hypothesis is
reified in all use cases since they all are expressed in
the GUI.
To address these hypotheses, we surveyed commer-
cially available laboratory specimenhandling computer
programs, including Biological Specimen Inventory
System (Information Management Services, Inc., http://
www.bsisystems.com), a virtual inventory system lacking
storage of radiological imaging studies, and a results-
handling component, and thus unable to be queried
for clinical analytic correlations. However, its web ser-
vice programming interface provided a useful specimen-
tracking component of a larger system. In review of
the application programming interface (API) documents,
we judged the programming interface to lack suffi-
cient power and flexibility to meet that desired com-
ponent role.
Biorepository informatics
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A biorepository conventionally supplies methods and
resources for the collection, processing, storage/inventory,
and distribution of biological specimens, all under a qual-
ity management program to promote consistence with
evolving standards (28). To serve the particular goal of
biomarker identification, this biorepository augments
the conventional offering with informatic resources for
the acquisition and storage of correlative clinical, labora-
tory, and imaging data.
Subjects
The eligible experimental subjects are human patients
whose clinical care includes sampling of at least one
paired lesion tissue and fluid (blood or cerebrospinal
fluid) sample as part of a biopsy or resective procedure.
At each participating institution, the research protocol
was approved by the institutional committee for human
subject research, and the subjects sign informed consent
before participating.
Specimens
In all instances, the tissue for EVand biomarker studies is
provided when clinical needs are met, and thus the tissue
is viewed as discarded tissue. Prior to or after diagnosis,
biofluids (blood, CSF, urine) may be obtained, aliquoted,
and banked for scientific research. Standard operating
procedures (SOPs) for sample acquisition are indexed by
date and code number for all samples with heavy reliance
on the recommendations of the International Society
of Extracellular Vesicles (Fig. 2) (25,26,29). The virtual
biorepository currently includes 3 fixed locations with
postal addresses (partially visible on the right hand panel
of Fig. 2) holding a total of 4,392 physical specimens.
Fig. 2. Main GUI screen shot. The portion controlled by the Google apps domain is cross hatched. Program functionality, data
structures, meta data including ontology networks, and asset relationships are uniﬁed into a single network graph theory model. This
model is renderedwith an open-source datavisualization library that we extended to offer interactive data queries and data editing (17).
In this example screen shot the mouse hovers over the Locations node, causing an overview map of this global virtual biorepository to
appear in the sliding window on the right.
William E. Butler et al.
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The use cases represent narratives of anticipated human
interactions with the system.
a. The field use case refers to use by study personnel.
Qualified study personnel may be present in the
operating room, the clinic, and the laboratory to
acquire tissue and biofluid specimens. The system
records the field site and provides unique identifiers
for subjects and specimens. The identifiers are applied
as bar codes to specimen containers.
b. The clinical data use case refers to records of clini-
cal presentation, laboratory findings, imaging studies
such as magnetic resonance (including the images
per se), comorbidities, medications, therapeutic con-
current clinical trials, therapeutic interventions, and
outcome metrics, including quality of life, progres-
sion-free survival at 6 and 12 months and overall
survival. These data are linked to specimens via bar-
codes to afford biomarker assessment via correlations
with tissue and biofluid EV analytic results.
c. The laboratory use case provides for preparative
techniques prior to storage or analysis of biofluids.
These techniques include use of specialized tubes,
low-speed and high-speed centrifugation, ultracentri-
fugation, filtration, addition of anticoagulants, addi-
tion of stabilizers such as lithium chloride, and
reversal of anticoagulants such as heparin. Specimens
may need to be prepared differently according to the
biofluid, time interval, or analytic requirements ac-
cording to different protocols. Recording is made
of processing and storage variables such as concomi-
tant medications, haemolysis, thrombocytopenia,
lymphopenia that may influence analytic results.
These SOPs may be contained in documents that
are stored in the systems document repository.
d. The specimen inventory use case refers to the loca-
tion tracking of all specimens, specimen containers,
and fixed storage facilities distributed globally. To
quickly locate a given specimen among potentially
millions distributed globally, the location of each
container and each specimen needs to be tracked.
Outer containers and buildings are tracked with
respect to their postal addresses and geo coordinates
(latitude and longitude). Internal containers and
specimens are tracked with respect to their external
container and the grid coordinate of their slot in
the external container. To find a given specimen, the
system thus produces a list of container bar codes
and grid coordinates. The specimen inventory use case
includes aliquots of specimens and the tracking of
residual aliquot quantities as they are consumed by
laboratory analysis. The system do not have at this
time an explicit method to record specimen-handling
exceptions such as those might occur with a freezer
failure.
e. The specimen query use case identifies biorepository
specimens to be selected by an investigator for research
studies. For example, when specimens are needed for
studies of glioma pseudo-progression (30), we support
a query of specimens from subjects with glioblastoma
who have undergone radiation and whose brain MRI
scans reveal oedema manifested by elevated T2 signal
and gadolinium enhancement. The system responds
to this query with a list of specimens that meet the
criteria along with their locations. These specimens may
then be transported to the investigators laboratory. The
specimen query, inventory,a n dtransport use cases work
in coordination.
f. The specimen transport use case allows the biorepo-
sitory to be virtual and globally distributed. Some
institutions may specialize in acquiring specimens by
virtue of their large clinical practices. Other sites may
have unique expertise in a particular molecular
analytic method. While this coupling enhances effi-
cient science, it requires the transport of specimens.
The specimen transport use case thus includes the
placement of specimens in a shipping box, recoding
the shipper-assigned tracking key, use of the track-
ing key to monitor the transport of specimens, and
the receipt acknowledgement and storage of the
specimens by the receiving site.
g. The collaborative science use case includes the provi-
sion of a common platform for investigators to
maintain activity calendars, bulletin boards, special
interest announcement lists, video-conference tools,
and data sharing. This supports the pooling of
documents that separate institutions may require such
as example documents for institutional committees for
research on human subjects, exemplar consent forms,
biofluid-handling SOPs, and investigator instruction
tutorials.
h. The clinical data use case refers to records of clini-
cal presentation, laboratory findings, imaging studies
(such as magnetic resonance including the images
per se), comorbidities, medications, therapeutic con-
current clinical trials, therapeutic interventions, and
outcome metrics, including quality of life, progres-
sion-free survival at 6 and 12 months and overall
survival. These data are linked to specimens via
barcodes to afford biomarker assessment via correla-
tions with tissue and biofluid EV analytic results.
These projected use cases drove the following design,
programming, and deployment decisions.
System design
The system consists of a custom application built in a
3-tier architecture as commonly employed in contem-
porary Internet commerce. The custom application is
integrated primarily via web services with several external
Biorepository informatics
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and its aggregate functionality.
The 3 tiers of the custom application include a
structured query language (SQL) server in the data tier,
a Java virtual machine (JVM version 1.7.x) in the middle
tier (31), and a client tier written in HTML version 5 and
JavaScript that is deployed to a web browser. We employ,
where available, open-source software libraries (Table I).
In the data tier, we selected Postgres version 9.x as
the SQL server for its maturity, robustness, and scal-
ability (32). We leverage its data trigger capabilities to
maintain an audit trail. When a record is updated or
deleted, the triggers instruct the SQL server to attach
a time stamp and copy the record to an audit trail data
base for later analysis as needed.
We selected JVM version 1.7.x for the middle
tier because its combination of performance, security,
language-type safety, memory management, and rich
collection of compatible libraries have led it to be the
leading language and platform for server applications
(31). Most of the middle-tier code is written in Java.
We are transitioning to Scala version 2.10.x because
it is more expressive and offers functional constructs
while preserving type safety (33). It compiles to Java
byte codes and has proven in this project to be trivially
interoperable with the preceding Java code. Moreover,
Scala is convenient for data import tasks because
it offers deployment as an interactive language (34).
This permits data import scripts to be developed in an
interactive fashion.
We employ an object-relational mapping library in the
middle tier to transport and operate on the data between
the data and client tiers. Because of the ontological
richness of biomedical vocabularies, we sought a library
that would facilitate the representation of a complex data
model in the GUI. With these desiderata, we selected
WebObjects because it has a mature object-relational
mapping system (Enterprise Objects Foundation) and a
rule-based way to map data objects to GUI objects
(Direct To Web) (3537). With D2W, many core tasks
such as presentation in HTML of query, list, and edit
screens can be programmed by means of editing a GUI
rules file  significantly reducing the quantity of hand-
written computer code that needs to be generated,
tested, and maintained. This may simplify the task of
modifying the system when the science grows in un-
expected directions.
In the client tier, the JavaScript language and the
jQuery library are used heavily in HTML to control use
of the bar code capture device, provide the widgets with
live links to the web service maintained by the US NCBO,
and implement the screens for visual navigation of the
program and data model (38,39).
The software components described earlier are termed
the custom application, but they do not comprise the
complete informatic system. The application is provided
as integrated feature of a larger, complete web-based
computing environment. The application was initially
provided as a portlet in a Liferay portal deployment
(40,41). It is now provided as a Google Gadget that
employs the OpenSocial specification (10,42). Thus, the
biorepository informatic system described in this paper
refers to the integration of this custom application with
a private Google Apps for Business account.
Data model
The data model is designed for the gathering of clinical
data (symptoms, signs, comorbidities, major interven-
tions, clinical laboratory findings, quality of life, and
outcomes) and imaging data (from computed tomogra-
phy and magnetic resonance imaging) as coupled to fluid
and tissue specimens (Fig. 3).
Specimen data are stored in a collection of tables.
There is a SpecimenAccession table that stores informa-
tion about the acquisition of the specimen such as
anatomic site, time, date, geo location, quantity, and
related information. This table has a to-many relationship
to the SpecimenFraction table that contains a bar code
identifier, geo location including a pointer to an enclosing
container, and a custody chain record. There are optional
pointers between the specimen, the imaging, and the
comprehensive clinical data tables.
There are tables that maintain administrative and reg-
ulatory compliance information. An audit trail is main-
tained of all data updates and deletions by coupled use of
a Postgres trigger as described earlier.
Other tables maintain information on study personnel
and study institutions, including documents pertaining to
and status of institutional committees for studies involv-
ing human subjects. The tables are mapped to Java objects
by the EOF object-relational mapping system included
in WebObjects (36).
Table I. Major open-source libraries that are used by the
custom application
Library Purpose
Postgres 9.x SQL database server and JDBC connector
Junit 4.x Code testing
Apache HTTP 2.x HTTP protocol
InfoVis JIT JavaScript client side visualization
JQuery 1.9 Client side control
Scala 2.9.x Scala language
Tomcat 6.x Java web application container
Wonder 5.x Java web application framework
The version is stated as Bmajor version .Bminor version ,
with ‘‘x’’ representing the migration of minor versions over the
course of the project.
William E. Butler et al.
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A unique, machine readable bar code is assigned to every
specimen, every specimen container, and every location
thatcontainscontainers.Forexample,alaboratoryfreezer
maintainedat 808Cmaycontainseveralracks,eachrack
may contain several drawers, each drawer may contain
several boxes with dividers, and each cell amidst the
dividers may contain a vial with frozen liquid specimen.
In this instance, a uniquebarcodewould be on the freezer,
the racks, the drawers, the boxes, and the vials.
We employ various methods for bar coding of vials and
containers as appropriate for the circumstances. For the
small vials to be deep frozen, we selected vials with pre-
printed bar codes (Thermo Scientific part #5001-0012).
For other bar codes, we employ a bar code printer that
prints them on an adhesive tape and then we apply that
label to the specimen container. For containers that are
already frozen at 808C and thus may not serve as a
sticky surface for a bar code sticker we employ vinyl
(Xpress Tags part #TG-2122-WH) or paper tags. The bar
code stickers are applied to the tags dry and at room
temperature, which are then applied to the frozen
container. The bar codes may be read (‘‘gunned’’) with
a commercial bar code scanner attached via a Universal
Serial Bus (USB) computer port (Hewlett Packard part
#EY022AA). The bar code scanner reads the identifier
code and places it at the cursor point in the active GUI
screen.
The specimen query, specimen inventory, and specimen
transport use cases all for a researcher to be able to search
for a specimen from a subject with desired properties, and
then for the system to provide a precise set of instructions
to physically find that specimen. Since the system is
intended to cover the specimen inventory use case with
potentially millions of specimens globally distributed
in many thousands of containers, the system main-
tains a recursive geometric map of all container and
specimen locations. This is achieved by maintaining in
the meta data area of the GUI a list of container types.
In the specimen inventory use case, when a bar code that
is applied to a new container is gunned, the system
recognizes it as a new container, and opens a window
prompting user to select the make and model of the
container from a drop-down list. When the selection is
made, the GUI can then present the contents of the
container as a grid of cells. The user places the screen
cursor in the field with the row and column correspond-
ing to the grid location of the actual specimen in the
container box, and then guns the specimen bar code.
This ties that specimen to its particular location in its
container. This geometric localization is performed
recursively for containers within containers. As a result,
the system provides globally geometric navigation of
all specimens (Fig. 4; an annotated version from video
screen capture is available from http://floorbiorepository.
org/resources/Locations.mp4). At the top level, where a
container is not within a container but instead is char-
acterized by its geographic longitude and latitude, its
location may be displayed on a geographic mapping
interface. For this purpose, this system makes calls to the
API of Google maps version 3 (43).
This recursive bar coded geo mapping allows for a
global drill down effect in the GUI whereby the user can
click with a computer mouse on a symbol representing
a container on Google maps. This opens a sub-window
with a geometric model of the container’s contents, and
the user can proceed until an individual specimen is
localized. Conversely, a usercan identifya specimen based
on a query that includes clinical characteristics as de-
scribed previously, and the system offers a ‘‘bread crumb’’
trail of containers leading to the specimen, thereby
facilitating the ability to find physicallya desiredspecimen
among potentially millions.
Ontology networks and other meta data
To support the specimen query and data archive and
reporting use cases, we designed the system to tag data
with terms from any of the ontologies maintained by the
US NCBO. Table II lists the ontologies currently in use.
The NCBO maintains numerous ontologies in a consis-
tent storage scheme that permits a system such as this to
easily import NCBO-maintained ontologies. Moreover,
the NCBO offers web services and a client side widget
written using the jQuery JavaScript library that makes
it convenient to include ontology-related data capture
tasks in an HTML GUI (14,39). The NCBO widget
offers predictive auto-completion behaviour. When a user
types characters into the provided text field, the widget
Subject arms
Demographics
Initial Encounter [1]
Clinical Snapshot [*]
Specimen Accession [*]
Image Analysis [*]
Analytic Results [*]
Fig. 3. Overview of the subject data model. The Clinical
Snapshot table maintains pointers to sub tables with multimodal
clinical data. The Specimen Accession table maintains pointers
to sub tables that track the global virtual specimen inventory.
The Analytic Results table maintains pointers to sub tables that
hold an analytic research methods catalogue and analytic
research data as tied to a particular specimen. There are cross
pointers not shown between these various tables. Cardinality
is in square brackets (* indicates 0 or more). Relationships
between the members of the arm are not depicted here.
Biorepository informatics
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a drop-down list of matched ontology terms from which
the user may select. A modification of this widget is
employed throughout this custom application for the user
to apply ontology tags to specific elements of multimodal
clinical data and to provide a validated vocabulary to
specify the anatomic source of a specimen. While certain
ontologies such as SNOMED are proprietary intellectual
property, their licensing terms are generous for biomedi-
cal research use (44,45).
The data model and the ontology comprise networked
data structures with intersections (Fig. 5); an annotated
version from video screen capture is available from http://
floorbiorepository.org/resources/FloorSemanticNetwork.
mp4. When a data element is tagged with an ontology
term in the GUI using the live widget described earlier,
the system creates an entry in a separate table that
associates the ontology term with the data element. This
allows live cross-cutting queries with ontology terms and
enables the use of ontology terms in the specimen query
and data archive and reporting use cases, and also allows
the use of ontology networks as navigation aids in the
network visualization GUI as described in the GUI
overview section.
Subjects may be enrolled in phase 2 or 3 clinical trials
of investigational agents given according to a defined
schedule. This trial information may be of importance in
interpreting the results of EV RNA or protein analyses.
The system maintains a list by subject of clinical trials,
with a link to the clinical trial identifier as assigned by
clinicaltrials.gov. Users may, in the GUI, record the
duration of enrolment in one or multiple trials. These
data is then available for query and analysis.
External integrations
Thissystemintegrateswithseveralexternalinformaticand
computer systems to enhance its functionality and reduce
de novo programming tasks. The external integrations are
listed in Table III. The live link to NCBO has been
described earlier.
Fig. 4. Two consecutive screen shots depicting the recursive geometric localization of specimens. The curved arrow represents the ﬂow
of screens when the link in the top row of the Freezer is clicked in the ﬁgure on the left. This gives a 99 matrix corresponding to the
vial slots in the white box. This allows for accountability of specimen locations arose the global biorepository. An annotated version
from video screen capture is available from http://ﬂoorbiorepository.org/resources/Locations.mp4.
Table II. Externally validated and maintained ontologies currently used in this system
Name Abbreviation NCBO Identifier Purpose
Foundational model of anatomy (46) FMA 1,053 Anatomic source of specimen
National Cancer Institute meta thesaurus (47) NCI-MT 1,032 Molecular target in analytic methods catalogue
Standard nomenclature in medicine (48) SNOMED 1,353 Tissue pathology, subject comorbidities, medical
interventions
The GUI employs where appropriate a JavaScript widget with a live web service connection to the US NCBO. An illustration of usage in
the GUI is available from http://floorbiorepository.org/resources/FloorSemanticNetwork.mp4.
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ality in several respects. The name floorbiorepository.org
was registered with the Internet Domain Name System
(DNS), and a Google Apps for Business account was
purchased for it. This account functions as the wrapper
for this informatics system. By means of administrative
screens supplied by Google, users of this system are as-
signed a login name and password by a floorbiorepository.
org administrator. Authorized users must be assigned to
a group within the floorbiorepository.org domain that
has authorization to use the various digital resources
of this system including the custom application. The
custom application described in this paper is deployed
in Linux (CentOs 5.x (46)) instances on Amazon Elastic
Compute Cloud (EC2) (48). It is embedded in the
floorbiorepository.org Google apps domain using the
OpenSocial and Google Gadget specifications. When an
authorized user logs into the system and navigates to this
custom application, a cryptographically signed token is
passed from the Google container to the embedded
application using the OAuth (a protocol for the secure
exchange of authentication and authorization between
cooperative systems) (49). The custom application main-
tains its own list of access permissions. When it receives
a cryptographically signed token that is unique to a user,
i ta l l o w sa c c e s st ot h a tu s e rt oe l e m e n t so fi n f o r m a -
tion according to its own policies. All exchanges of
information between integrated systems are encrypted.
In Fig. 2, the cross-hatch area depicts the portion of
a typical screen handled by Google Apps whereas the
central non cross-hatched area is the custom applica-
tion. It maintains a set of access policies separate from
the Google Apps domain. The privacy and security expo-
sures and their respective countermeasures are further
described in the Privacy, security, and permissioning
section.
A similar functionality was implemented with the
open-source portal Liferay, where the custom application
is supplied as a portlet (per the JSR-268 specification)
and the Liferay application provides password manage-
ment, authentication, document sharing, calendar shar-
ing, and social computing services (40,41). Google Apps
and Liferay both furnish document libraries that may
be user for the shared editing and storage of study
documents such as protocols, consent forms, grant
applications, manuscripts, and institutional human sub-
jects committee or other regulatory documents. However,
we switched to Google Apps as the main option because
the users are more familiar with the various Google
applications than the Liferay ones, and because Liferay,
as a full open-source product, requires one fully to
administer the deployment whereas Google Apps are
administered by Google. However, the Liferay integration
remains as an option.
Google Spreadsheets are used in this system as a
medium for data exporting and reporting. The Google
Spreadsheets offering includes Apps Script, a program-
ming language and environment that includes facilities
for accessing external web services as well as for adding
menu items in the spreadsheet GUI (50). We supply a code
written in Apps Script to retrieve anonymized subject
Subject
Clinical Data  Radiology  Experimental Data Specimens Ontologies
FMA
SNOMED
NCI-MT
ontology tag
retrieval
field-data retrieval
Fig. 5. The data model and the ontology networks are both structured as networks of hierarchical data with intersections. The
intersections occur at those particular ﬁelds in the datawhere ontology tags are applied to allow standardized queries. An illustration in
the GUI is available from http://ﬂoorbiorepository.org/resources/FloorSemanticNetwork.mp4.
Table III. External integrations
Functionality External resource
Ontologies NCBO
Track concurrent trials
enrolments
clinicaltrials.gov
Password management, user
authentication
Google Apps Domain
Authorization Google Apps Domain
Data exports and reports Google Apps Script, Google
spreadsheets
Data archives Amazon S3
Document sharing Google Docs
Biorepository informatics
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authorization from the custom application and to insert
that data into Google Spreadsheets. This functionality is
embedded in selected spreadsheets such that the invo-
cation in the spreadsheet menu of a refresh command
causes the retrieval of data from the application into
that spreadsheet. This offering allows the ad hoc analy-
sis of data by authorized study personnel (Fig. 6). More-
over, direct access to the SQL tier may be afforded for
analysis for research needs not met by data in a spread-
sheet format.
Access to this spread sheet pull capability is com-
partmented. Authorized users with site scope permis-
sion at each participating institution may pull data
submitted by that institution. Authorized users with
protocol scope permission may pull data pooled across
all institutions.
GUI overview
We treat the top levels of the GUI in the custom
application as a network data visualization problem. In
this formulation, the elements of the data model, meta
data, and of program functionality are treated as nodes
and the relations between them as edges in a graph
(e.g. see the left side of Fig. 2). As a rendering library,
we chose the SpaceTree module of the InfoVis JavaScript
library (27). Since this library is open source, we were
able to extend it to meet our needs by attaching event
handlers to the Document Object Model (DOM) ele-
ments that represent nodes as InfoVis renders them in
the network graph. The event handlers respond to mouse
clicks on the visual node as appropriate, for example,
by opening tabular data editing forms on a sliding side
window of the GUI. Moreover, we created a declarative
programming interface between the InfoVis JavaScript
library and the D2W rule-based GUI programming
system. We hope this declarative interface facilitates the
adaptation to new data structures that may appear in the
course of EV science.
The top level nodes in the main screen of the GUI of
the custom application are Primary Data, Meta Data,
Workflow, Assets, and Team (Fig. 2). When a user clicks
on a node, child nodes appear. Some nodes offer extra
options, as cued by small icons in the node. For example,
in depth information on the topic of the clicked node may
appear on a sliding window on the right side of the
Fig. 6. Google spreadsheets may be programmed with the Apps Script programming language and library to make encrypted web
service calls to the custom application to retrieve fresh data with which to populate spreadsheets and related analysis and reporting
tools. This allows the fresh retrieval of data for analysis as the scientiﬁc needs may dictate.
William E. Butler et al.
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to view more detail (in Fig. 2 the right side window is
unexpanded).
Privacy, security, and permissioning
Table IV lists the privacy and security exposures that
were encountered by this system with the correspond-
ing protective measures. The system conforms to best
practices for protection and storage of medical grade
data. This includes written policies, checklists as well
as confidentially agreements to be signed by investigator-
users, and related measures to adhere to the privacy re-
quirements of the Health Insurance Portability Act of
America (HIPAA) (52). To adhere to the security require-
mentsofHIPAA, thesystememploysencryption through-
out coupled with password policies (53). The U.S. Food
and Drug Administration (FDA), in addition to the
Privacy and Security Rules in HIPAA, has guidance
documents pertaining to the integrity of research data
(54). This system conforms to those guidance documents.
The system releases permission parsimoniously to authen-
ticated users to view and edit subject information on a
need to know basis. Authorized users may have one of
two types of data access scope, site scope and protocol
scope. Site scope entitles a user to view and edit data that
originates from the user’s institution. Most authorized
users have site scope. Protocol scope entitles users to view
aggregates from across all institutions. Only the overall
principal investigator and delegates have protocol scope.
For global scale deployment, the World Medical Asso-
ciation provides policy guidance for medical research
privacy,andthereappearstobeconvergenceintherequire-
ments of various nations (5557).
Cloud deployment
The application is deployed as two separate instances of
an EC2 server each running Linux CentOs 5.x, which
includes the security enhancements package SELINUX
contributed by the United States National Security
Agency (46,58). Each server has 2 gigabytes of random
access memory. One server holds the database (Postgres
version 9.x) and is not web-accessible. There is full disk
encryption on the disk that holds the database. There are
daily encrypted backups of the database, including the
audit trail. The other server runs the middle tier. The Java
application is deployed in a Tomcat 6.x container (59).
Calls to the application are mediated by Apache 2.x httpd
and forwarded to the Tomcat container (60). Encryption
policies are stipulated declaratively in the configura-
tion files of the Apache 2.x httpd and Tomcat layers
declaratively, in addition to in the wrapper (Google Apps
or Liferay) and custom application. As per routine,
the EC2 server instances are behind a security firewall
(Fig. 7).
Results
The virtual biorepository currently includes 3 fixed loca-
tions with postal addresses (Fig. 2). It holds now 4,392
physical specimens that were acquired in 1,443 accessions
from 611 subjects. Of those accessions, 1,065 (73.8%) are
fluid and 378 (26.2%) are solid tissue.
The specimen anatomic sources are presented with
respect to the preferred ontology name given by the
Foundational Model of Anatomy in Table V (61,62) and
the pathological diagnoses of tissue specimens with res-
pect to SNOMED in Table VI (63).
Discussion
We report the initial deployment of a biorepository
informatic system whose design is driven by some
hypothesized properties of future human EV biomar-
ker research. We hypothesize clinical and basic science
research centres collaborating across the world that obli-
gate a coordinated virtual, global specimen inventory
management system with global document sharing and
social computing features. We hypothesize that novel
diagnostic, prognostic, response, toxicity, molecular path-
way, and EV biomarker analytics have the best value
when correlated with multimodal clinical data, so we
include features for multimodal clinical data capture and
correlation with experimental EV analysis. We anticipate
the need to perform analytics on tightly defined novel
patient population cohorts linked by age, tumour appear-
ance on imaging, response or resistance to therapy. We
anticipate that EV science may turn in as yet unknown
directions, so we include a flexible data model and flexible
GUI enriched by externally maintained and validated
ontologies. From these hypotheses we derived the use
cases that the system ought to support and evolve with
Table IV. Security and privacy measures
Exposure Measure
Passwords Required. Externally managed. Password
policies in effect.
Human practices HIPAA checklist
Web access HTTPS throughout. Session timeouts.
Narrowly scoped access permission.
Server operating
system
Security-enhanced Linux (SELinux) from US
NSA
Server data
storage
Full disk encryption
Server access Certificate-based, not password
Data centre (51) Physical security, multiple security
certifications and audits
Data archives Redundant encrypted copies at multiple
physical sites
Database server
access
Behind firewall, not web-accessible
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specimen inventory, specimen query, specimen transport,
data archive and reporting, and collaborative science
use cases. The use cases drove the data model design,
the software code creation, the external integration
selections, and the deployment decisions.
This software development process where one hypothe-
sizes needs, builds the system, evaluates its usage, and
rebuilds it accordingly, shares features with the software
development methodology named Behavior Driven De-
velopment (BDD) (64). In BDD, the challenges recur-
sively are identified first, and design and deployment
choices follow. To some extent, the flexibility to handle
unknowability was built into the system. One method is
by grouping all elements that belong in the GUI into a
single network graph model that is then rendered visually,
we hope to allow complex and possibly evolving elements
to be intuited visually. A second method is by employing
a rule-based GUI programming system, that introspects
on the data model and draws GUI elements accordingly,
we increase the ease with which evolutions in the data
model can be incorporated. If over time the challenges
change or the current system as designed does not meet
them satisfactorily, we aim to re-evaluate and change the
system accordingly.
Firewall
Web Server
Apache 2.x
https
App Server
Java 1.7.x
Tomcat 6.x
ajp
ssh
user 1
system
administator
S3
archive
Data Server
Centos 5.x (SELinux)
Full disc encryption
Postgres 9.x
jdbc
user 2
...
Centos 5.x (SELinux)
https
blowfish encryption blowfish encryption
Fig. 7. Deployment architecture. The layering enhances stability and security.
Table V. Specimen sources reported by preferred ontology name
per Foundational Model of Anatomy (50,52)
Name No.
Serum 841 (58.2%)
Segment of brain 307 (21.3%)
Plasma 223 (15.5%)
Spinal cord 50 (3.5%)
Frontal lobe 11 (0.8%)
Temporal lobe 4 (0.3%)
Cerebellum 3 (0.2%)
Occipital lobe 2 (0.1%)
Cerebrospinal fluid 1 (0.1%)
Thalamus 1 (0.1%)
Table VI. Tissue pathological diagnoses by preferred ontology
name per SNOMED (53)
Name No.
Glioblastoma multiforme of brain 150 (46.0%)
Secondary malignant neoplasm of brain 77 (23.6%)
Astrocytoma, anaplastic 22 (6.7%)
Dysembryoplastic neuroepithelial tumour 16 (4.9%)
Meningioma 8 (2.5%)
Radiation injury with inflammation 7 (2.1%)
Gliosis 6 (1.8%)
Malignant melanoma 5 (1.5%)
Indeterminate 4 (1.2%)
Oligodendroglioma, anaplastic 4 (1.2%)
Anaplastic oligoastrocytoma 3 (0.9%)
Pleomorphic xanthoastrocytoma 3 (0.9%)
Gliosarcoma 3 (0.9%)
Oligodendroglioma 3 (0.9%)
Ependymoma, anaplastic 2 (0.6%)
Myosarcoma 2 (0.6%)
Epidermoid cyst of brain 2 (0.6%)
Necrotic tumour 2 (0.6%)
Central neurocytoma 1 (0.3%)
Cavernous hemangioma 1 (0.3%)
Low grade glioma 1 (0.3%)
Cerebral amyloid antipathy 1 (0.3%)
Primary central nervous system lymphoma 1 (0.3%)
Hematoma 1 (0.3%)
Acoustic neuroma 1 (0.3%)
Pilocytic astrocytoma 1 (0.3%)
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growth. We selected the InfoVis library because it excels at
the display of network graph data, and as an open-source
project, its source code is available for modification to
meet the custom needs of this system (27). Among other
JavaScript-based data visualization open-source libraries
that offer network graph visualization modules, Data
Driven Documents (D3.js) has a broad range of applic-
ability, and has been used in various bioinformatics appli-
cations such as gene ontology visualization (65,66). The
selection here of InfoVis is a matter of convenience, and
other options such as D3.js could be adopted when they
meet better the needs as may arise.
We selected Postgres as the database server software
because of its resilience, performance, and because it can
be configured to handle maintenance of the data audit
trail. However, as a relational database it does not map
naturally to network graph data because each node
traversal requires an expensive SQL join operation (67).
A number of graph databases have been introduced that
are optimized for the storage of data richly populated
with nodes and edges. These graph databases have effi-
cient traversal of edges during query tasks (19,67). A
graph database might be programmed more conveniently
to coordinate with a network graph oriented GUI as we
have implemented here.
One graph database, Bio4j, a bioinformatics-oriented
derivative of Neo4j, comes prepopulated with data from
UniProt KB, Gene Ontology, UniRef, RefSeq, NCBI
taxonomy, and Expasy Enzyme DB (47). At installation,
Bio4j version 0.8 thus has more than 190 million nodes
and more than 1.2 trillion edges (relationships between
nodes) (68). A transition from Postgres to Bio4j would
offer the inclusion of these ontologies for potential use
in this system, possibly affording in turn a rich plat-
form for the incorporation of an EV ontology. Such an
ontology may leverage underway efforts in EV systema-
tics such as ExoCarta, Vesiclepedia, and LIPID MAPS
(1113,69). The combination of Bio4j with this system’s
graph-oriented GUI may also offer a convenient way
to implement the visualization of EV-related metabolic
pathways in relation to other metabolic, proteomic, or
genomic pathways.
Since biomedical software applications commonly have
complex data models, one may expect it to be helpful
to have application authoring systems that can automate
the generation of the GUI from the data model (7073).
By reducing programmer workload, these extend the
possible scope of other programming tasks. However,
we find these systems to be inflexible for this applica-
tion because we need the GUI to render differently
according to the context. For example, the same data
elements may need to be grouped differently, be editable,
or displayed at all according to the user’s authorizations
and the use case. Instead, we prefer a system where the
GUI behaviours may be coded in a set of rules that a
programmer can edit. The result, a GUI that requires less
programmer work to generate than if the client side code
were written by hand, yet remains programmable within
large bounds. The resulting compromise meets well the
needs of developing research biomedical GUIs, and
there is active research in the area of rule-based GUI
generation (7073).
The various use cases are deployed to the user on a
web browser in this system as currently programmed and
deployed, but some use cases may be supported better by
lighter weight, mobile table-style devices with the applica-
tion written in a native library rather than for a web
browser. For example, the clinical data use case may
call for personnel to go to an outpatient clinic setting
to capture clinical and outcomes data. The specimen
inventory use case may call for personnel to present to a
pathology laboratory to acquire tissue not needed for
diagnosis. In each of these instances, the use case may
be served more efficiently if the study personnel carried
a tablet device with which to enter a new specimen and
its bar code or to capture more clinical data. We intend
thustoobservetheusagepatternsofthecurrentsetup,and
as needed create, test and deploy tablet device interfaces.
Virtualized (cloud) deployment allows increased spe-
cialization and lowers the cost of deployment (74). The
specialization refers both to hardware and software
services. The hardware includes the rental of computer
units, input/output bandwidth, and long-term storage.
The software services are, among others, the maintenance
of passwords and the offering of authentication and
authorization services. Systems administration tasks are
automated by the data centre or are managed by data
centre personnel, who have training in and conform
to best practice guidelines in the numerous tasks involved
in deployment. This lowers the complexity and cost of
global, multitiered deployment. This, in turn, allows the
developers to focus on design and programming.
The cloud deployment provider selected for this
deployment meets security standards much higher than
can be met for example with self-managed deployment.
The data centres offer multilayered firewalls, intrusion
detection, and proactive security policies. The cloud
deployment provider selected for this custom application
has multiple security certifications and has undergone
multiple security and quality audits. These include ISO
27001 certification (75), Payment Card Industry (PCI)
Data Security Standard (DSS) Level 1 certification,
Federal Information Security Management Act (FISMA)
Moderate Authorization and Accreditation, and Federal
Information Processing Standard (FIPS) Publication
1402 validation (76). Moreover, it hosts HIPAA-
compliant commercial services.
This biorepository informatic system is currently in an
early phase of implementation. It is chiefly tasked now
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data, and the geo tracking of specimens. As time passes,
the usage patterns will be where the underlying hypoth-
eses are tested. Other informatic systems with a narrower
purpose may prove to be a better choice for specific tasks
covered comprehensively by this system. For example,
projects such as OpenPHACTS may provide generic
tools for data storage and sharing that may obviate this
independent offering in this system (77). Other systems
may be embedded into the GUI of this one if their archi-
tecture lends to integration with single sign on services
and the cross embedding of HTML fragments.
The US National Institutes of Health published a
request for applications to build an informatic system
for extracellular RNA that includes the concept of
an ExRNA Atlas (78). If an EV ontology were to be
developed, for example, as part of the proposed ExRNA
Atlas, it could be added to the networkof ontologies used
by this and other systems participating in EV research.
The unified representation of EV-related information
might help disparate computer systems coordinate a
response to automated or human-directed query and
retrieval tasks. These disparate systems may include
existing repositories of EV data (1113,79). The sum
may be a semantic web that accelerates insight into the
integrative biology of EVs, including their possible role
in intercellular and inter-organ communication (80,81).
Conclusion
We created an informatics system to support EV biomar-
ker research. This biorepository informatics system repre-
sents a hypothesis-driven experiment on the future course
ofmicrovesicle research. Rigorous methods do not exist to
testtheperformanceofthissystemagainsttheactualneeds
of the field as it develops, so the question of whether the
hypotheses represented here is confirmed by the data will
likely be addressed only qualitatively. We hope we have
built a system that may evolve with EV science.
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